Psychiatr. praxi. 2013;14(4):169-173
Therapeutic response to complex treatment in patients with social phobia
- 1 Klinika psychiatrie, LF UP a FN Olomouc
Introduction: In social phobia as well as other anxiety disorders is pharmacoresistancy an important problem. Exact predictors of the
therapeutic response are not known yet. The aim of our study was to prove the efficacy of our treatment program and identify predictors
of therapeutic response to complex pharmacotherapeutical and cognitive behavioral treatment in pharmacoresistant patients.
Methods: We analysed data for 50 probands diagnosed with social phobia hospitalized on psychotherapeutical department of Department
of Psychiatry, University Hospital Olomouc. We investigated basic demographic data (age, disease duration, age of onset), index of used
antidepressant and scores of main raiting scales (LSAS, CGI, BAI, BDI, DES a DES-T). We also evaluated an influence of personality disorders.
Results: There was a statisticly significant decease in symptomatology in all rating scales during the treatment. Change in LSAS (ratio of initial
to last measured score) positively correlated only with age of onset of the disorder. Level of dissociation measured by DES correlated with initial
BAI score, in case of DES-T with initial BAI and BDI. We proved statistically significant difference in intial BAI score when splitting to group to
responders and non-responders by final CGI. There was no statistically significant result if we concentrate on influence of personality disorders.
Conclusions: In our study we proved efficacy complex therapeutical program in treatment of pharmacoresistant patients with social
phobia. Age of onset of disorder positively correlated with changes in LSAS during the treatment.
Keywords: social phobia, pharmacotherapy, CBT, complex treatment, therapeutic reaction, predictors
Published: November 1, 2013 Show citation
References
- Praško J, Laňková J. Úzkostné poruchy - doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře, 2006.
- Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6): 593-602.
Go to original source... 
Go to PubMed... - Stein MB, Kean YM. Disability and Quality of Life in Social Phobia: Epidemiologic Findings. Am J Psychiatry 2000; 157: 1606-1613. Go to original source... Go to PubMed...
- Safren SA, Heimberg RG, Brown EJ, Holle C. Quality of life in social phobia. Depression and Anxiety 1996/1997; 4(3): 126-133. Go to original source...
- Kessler RC, McGonagle K, Zhao S, Nelson C, Hughes M, Eschleeman S, Wittchen HU, Kendler KS. Lifetime and 12-months prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8-19. Go to original source... Go to PubMed...
- Praško J, Prašková H. Sociální fobie In: Seifertová D, Prasko J, Horáček J, Hoschl C (eds): Postupy v léčbě psychických poruch. Algoritmy České neurofarmakologické společnosti. Amepra, Medical Tribune, Praha 2008; 257-274.
- Ameringen M, Mancini C, Pipe B, Bennett M. Optimizing Treatment in Social Phobia: A Review of Treatment Resistance. CNS Spectrums 2004; 9(10): 753-762. Go to original source... Go to PubMed...
- Clark DM, Ehlers A, McManus F, et al. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo controlled trial. J Consult Clin Psycol. 2003; 71: 1058-1067. Go to original source... Go to PubMed...
- Kawaguchi A, Watanabe N, Nakano Y, Ogawa S, Suzuki M, Kondo M, Furukawa TA, Akechi T. Group cognitive behavioral therapy for patients with generalized social anxiety disorder in Japan: outcomes at 1-year follow up and outcome predictors. Neuropsychiatric Disease and Treatment 2013; 9: 267-275. Go to original source... Go to PubMed...
- Acarturk C, Cuijpers P, Straten A, Graaf R. Psychological treatment of social anxiety disorder: meta-analysis. Psychological medicine 2009; 39: 241-254. Go to original source... Go to PubMed...
- Cameron OG, Thyer BA, Feckner S, Nesse R, Curtis GC. Behavior therapy of phobias: predictors of outcome. Psychiatry Res. 1986; 19: 245-246. Go to original source... Go to PubMed...
- Wlazlo Z, Schroeder-Hartwig K, Hand I, Kaiser G, Munchau N. Exposure in vivo vs social skills training for social phobia: longterm outcome and differential effects. Behav Res Ther. 1990; 28: 181-193. Go to original source... Go to PubMed...
- Scholing A, Emmelkamp PMG. Prediction of treatment outcome in social phobia: a cross-validation. Behav Res Ther. 1999; 37: 659-670. Go to original source... Go to PubMed...
- Mululo SCC, Menez GB, Vigne P, Fontenelle LF. A review on predictors of treatment outcome in social anxiety disorder. Revista Brasileira de Psiquiatria 2012; 34(1): 92-100. Go to original source... Go to PubMed...
- Mezinárodní klasifikace nemocí - 10. revize, MKN-10 (1. vydání); Maxdorf Praha; 1996.
- Guy W (ed.): ECDEU Assessment manual for psychopharmacology. Rockville, U.S. DHEW; 1976. Go to original source...
- Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67(3): 588-597. Go to original source... Go to PubMed...
- Beck AT, Epstein N, Brown G, Steer RA. An Inventory for Measuring Clinical Anxiety: Psychometric Properties. J Consult Clin Psychol 1988; 56(6): 893-897. Go to original source... Go to PubMed...
- Beck AT, Steer RA. Manual for the Beck Anxiety Inventory. Psychological Corporation. San Antonio TX 1993.
- Bernstein EM, Putnam FW. Development, Reliability, and Validity of a Dissociation Scale. J Nerv Ment Dis 1986; 174(12): 727-735. Go to original source... Go to PubMed...
- Liebowitz MR. Social phobia. Modern Problems of Pharmacopsychiatry 1987; 22: 141-173. Go to original source... Go to PubMed...
- Ptáček R, Bob P, Paclt I, Pavlát J, Jasová D, Zvolský P, Raboch J. Psychobiology of dissociation and its clinical assessment. Neuroendocrinol Lett 2007; 28(2): 191-198. Go to PubMed...
- Waller NG, Ross CA. The prevalence and biometric structure of pathological dissociation in the general population: Taxometric and behavior genetic findings. Journal of Abnormal Psychology 1997; 106(4): 499-510. Go to original source... Go to PubMed...
- EMEA, 2002: http://www.ema.europa.eu/pdfs/human/ ich/0135 95en.pdf. 20. 3. 2009.
- Praško J, Raszka M, Adamcová K, Grambal A, Kopřivová J, Kudrnovská H, Látalová K, Vyskočilová J. Predicting the therapeutic response to cognitive behavioral therapy in patients with pharmacoresistant obsessive-compulsive disorder. Neuro Endocrinol Lett. 2009; 30(5): 101-110. Go to PubMed...
- Pastucha P, Praško J, Grambal A, Látalová K, Sigmundová Z, Sykorová T, Ticháčková A. Panic disorder and dissociation - comparison with healthy controls. Neuro Endocrinol Lett. 2009; 30(6): 774-778. Go to PubMed...
- Chen J, Nakano Y, Ietzugu T, Ogawa S, Funayama T, Watanabe N, Noda Y, Furukawa TA. Group cognitive behavior therapy for japanese patients with social anxiety disorder: preliminary outcomes and their predictors. BMC Psychiatry 2007; 10(7): 59-69. Go to original source... Go to PubMed...
- De Menezes GB, Fontenelle LF, Versiani M. Gender effect on clinical features and drug treatment response in social anxiety disorder (Social Phobia). Int J Psychiatry Clin Pract. 2008; 12(2): 151-155. Go to original source... Go to PubMed...